Preparation method of przewatanshinone A

By reacting with ether or nitrile solvents in the presence of selenium dioxide, the problem of low yield of sanshinone preparation of sanshinone methin in the prior art was solved, and efficient preparation of sanshinone methin was achieved. , yield and purity are significantly improved.

CN118978564APending Publication Date: 2024-11-19SPH NO 1 BIOCHEM & PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411058908.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In the prior art, the preparation yield of Purple Salvia miltiorrhizae is relatively low and there is a lack of efficient artificial synthesis methods.

Method used

Using sodium tanshinone IIA sulfonate as raw material, in the presence of selenium dioxide, the reaction is carried out using ether or nitrile solvents, and the reaction conditions such as temperature, time and molar ratio are controlled, followed by concentration, extraction, drying and purification steps to improve production. Rate.

Benefits of technology

The high yield preparation of Purple Salvia miltiorrhizae is achieved, with simple steps, high yield, and purity of up to 98.5%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978564A_ABST
    Figure CN118978564A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of przewatanshinone A. The preparation method comprises the following steps: in a solvent, under the action of selenium dioxide, tanshinone IIA sodium sulfonate is subjected to a reaction as shown in the specification to obtain przewatanshinone A, the solvent is an ether solvent or a nitrile solvent. The preparation method disclosed by the invention is simple and convenient to operate and relatively high in synthesis yield. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for preparing danshenone A. Background Art

[0002] Purple danshen alkaloids A is mainly extracted from Danshen medicinal materials, and its content is very low. Studies have found that its oxygen resistance is stronger than tanshinone IIA, and its antibacterial effect is also stronger than cryptotanshinone, and it is effective against a variety of experimental tumor animals. Patent CN109824753 reports that purple danshen alkaloids A has a significant inhibitory effect on indoleamine 2,3-dioxygenase IDO and tryptophan 2,3-dioxygenase, and can be used to prepare drugs for IDO or TDO-mediated diseases, such as glioblastoma, bladder cancer, breast cancer, etc. Patent CN102961384 discloses the important use of purple danshen alkaloids A in the medical field. CN107118254 and CN 105884856 disclose the use of it as an intermediate to prepare other drugs.

[0003] However, in the prior art, danshen A is mainly extracted from natural products, and there are few artificial synthesis methods. CN107522857 discloses that danshen A is prepared from tanshinone IIA using 1,4-dioxane as solvent in the presence of selenium dioxide. However, the reaction yield of this method is only 25%. Therefore, it is of great significance to develop a new method for preparing danshen A. Summary of the invention

[0004] The technical problem to be solved by the present invention is that the yield of preparing purple danshen A in the prior art is low; to this end, the present invention provides a method for preparing purple danshen A. Compared with the traditional process, the method is simple to operate and has a higher yield in preparing purple danshen A using sodium tanshinone IIA sulfonate as a raw material.

[0005] The present invention provides a method for preparing purple danshen amine, which comprises the following steps: in a solvent, under the action of selenium dioxide, sodium tanshinone IIA sulfonate is subjected to the following reaction to obtain purple danshen amine; the solvent is an ether solvent or a nitrile solvent;

[0006]

[0007] The ether solvent is a conventional ether solvent in the art. In some embodiments, the ether solvent is tetrahydrofuran, 3-methylfuran, dioxolane or 1,4-dioxane, for example, 1,4-dioxane.

[0008] The nitrile solvent is a conventional nitrile solvent in the art. In some embodiments, the nitrile solvent is acetonitrile, propionitrile or butyronitrile, such as acetonitrile.

[0009] In some embodiments, the volume mass ratio of the solvent to the sodium tanshinone IIA sulfonate is 20-80 mL / g, preferably 20-55 mL / g, such as 25.3 g / mL or 50.5 mL / g.

[0010] In some embodiments, the molar ratio of the sodium tanshinone IIA sulfonate to the selenium dioxide is 1:(1-5), preferably 1:(1-4), for example 1:2.

[0011] In some embodiments, the reaction temperature is 85-110°C, preferably 90-100°C, such as 90°C.

[0012] In some embodiments, the reaction time is 2-8 h, more preferably 4-6 h, such as 5 h.

[0013] In some embodiments, the reaction further comprises a post-processing step after completion, and the post-processing step includes concentration, extraction, drying and purification.

[0014] In some embodiments, the organic solvent used in the extraction is ethyl acetate, acetone, dichloromethane, chloroform or 1,2-dichloroethane, such as dichloromethane.

[0015] In some embodiments, the drying is performed using a desiccant, and the desiccant is anhydrous sodium sulfate and / or anhydrous magnesium sulfate, preferably anhydrous sodium sulfate.

[0016] In some embodiments, the purification step is a conventional purification method for this type of compound in the art, such as column chromatography separation (dichloromethane:methanol=(10-50):1) or preparative plate separation (dichloromethane:methanol=(30-50):1).

[0017] In some embodiments, the solvent is acetonitrile or 1,4-dioxane, the molar ratio of the sodium tanshinone IIA sulfonate to the selenium dioxide is 1:(2-4), the volume mass ratio of the solvent to the sodium tanshinone IIA sulfonate is 20-55 g / mL, and the reaction temperature is 90°C.

[0018] In some embodiments, the materials for the reaction are sodium tanshinone IIA sulfonate, selenium dioxide and the solvent.

[0019] In some embodiments, in the reaction, sodium tanshinone IIA sulfonate is first added to the solvent, and then the selenium dioxide is added.

[0020] Without violating the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.

[0021] The positive improvement effect of the present invention is that the present invention provides a method for preparing danshenone A using sodium tanshinone IIA sulfonate as a raw material, the method has simple steps and a high yield. DETAILED DESCRIPTION

[0022] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods without specific conditions in the following embodiments are selected according to conventional methods and conditions, or according to the product specifications.

[0023] The sodium tanshinone IIA sulfonate used in the following examples can be prepared according to the microchannel continuous flow technology described in Example 20 described in the patent document CN 113861263 A published by Shanghai No. 1 Biochemical Pharmaceutical Co., Ltd.

[0024] The following examples use Shimadzu LC-2030C Plus high performance liquid phase for purity detection and analysis, chromatographic conditions: ZORBAX SB-C18 chromatographic column (4.6×150 mm, 5-micton), mobile phase A: 20 mM KH2PO4+0.5% triethylamine (pH 4.0)-methanol (60:40), mobile phase B: 20 ​​mM KH2PO4+0.5% triethylamine (pH 4.0)-methanol (20:80). Gradient elution program: flow rate 1.0 mL / min, column temperature 25°C, detection wavelength 271 nm, injection volume 10 μL.

[0025] Example 1

[0026]

[0027] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate in a 50 mL single-necked flask, add a magnetic bar and 10 mL of acetonitrile, stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, cool to room temperature and remove the solvent under reduced pressure, add 50 mL of dichloromethane to dissolve, and then extract and wash with water twice (50 mL * 2). Dry with anhydrous sodium sulfate, filter, remove the solvent from the filtrate under reduced pressure, mix the sample with silica gel and load it on the column, use dichloromethane / methanol system (dichloromethane: methanol = (10-50): 1) to separate the sample, and combine and concentrate the eluent to obtain 201 mg of red solid, with a yield of 65% and a purity of 98.5%. The high-resolution mass spectrum of the red solid purple danshen A obtained in this example, C 19 H 18 O4(M+Na) + =333.1097, 1 H NMR and 13 C NMR is as follows:

[0028] 1 H NMR (600MHz, DMSO-d6) δ7.78(d,J=9.6Hz,1H),7.72(s,1H),7.52(d,J=9.6Hz,1H),5.23(t,J=6.0Hz,1H) ,4.56(dd,J=6.0,2.4Hz,2H),3.30(t,J=6.0Hz,2H),1.71–1.69(m,2H),1.60–1.59(m,2H),1.27(s,6H). 13 C NMR (151MHz, DMSO-d6) δ182.2,174.5,160.7,149.4,142.9,142.2,133.4,126.9,126.6,126.4,119.9,118.1,54.6,37.4,34.3,31.4,29.5,18.7.

[0029] Example 2

[0030] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate in a 50 mL single-necked flask, add a magnetic bar and 10 mL of 1,4-dioxane, stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, cool to room temperature, remove the solvent under reduced pressure, add 50 mL of dichloromethane to dissolve, and then extract and wash with water twice (50 mL * 2). Dry with anhydrous sodium sulfate, filter, remove the solvent from the filtrate under reduced pressure, mix the sample with silica gel and load it on the column, use dichloromethane / methanol system (dichloromethane: methanol = (10-50): 1) to separate the sample, and combine and concentrate the eluent to obtain 125 mg of red solid, with a yield of 40% and a purity of 96.7%.

[0031] Example 3

[0032] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate in a 50 mL single-necked flask, add a magnetic bar and 10 mL of acetonitrile, stir, then add 222 mg (2.0 mmol, 2.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, cool to room temperature, remove the solvent under reduced pressure, add 50 mL of dichloromethane to dissolve, and then extract and wash with water twice (50 mL * 2). Dry with anhydrous sodium sulfate, filter, remove the solvent from the filtrate under reduced pressure, mix the sample with silica gel and load it on the column, use dichloromethane / methanol system (dichloromethane: methanol = (10-50): 1) to separate the sample, and combine and concentrate the eluent to obtain 152 mg of red solid, with a yield of 49% and a purity of 97.8%.

[0033] Example 4

[0034] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate in a 50 mL single-necked flask, add a magnetic bar and 20 mL of acetonitrile, stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, cool to room temperature, remove the solvent under reduced pressure, add 50 mL of dichloromethane to dissolve, and then extract and wash with water twice (50 mL * 2). Dry with anhydrous sodium sulfate, filter, remove the solvent from the filtrate under reduced pressure, mix the sample with silica gel and load it on the column, use dichloromethane / methanol system (dichloromethane: methanol = (10-50): 1) to separate the sample, and combine the eluents and concentrate to obtain 181 mg of red solid, with a yield of 58% and a purity of 98.3%.

[0035] Comparative Example 1

[0036] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate into a 50 mL single-necked flask, add a magnetic bar and 10 mL of methanol, stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, take a sample for HPLC detection, and there is basically no purple danshenone A product, so no subsequent treatment is performed.

[0037] Comparative Example 2

[0038] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate into a 50 mL single-necked flask, add a magnetic bar and 10 mL of ethanol, stir, and then add 444 mg (4.0 mmol, 4.0equiv) was heated to 90°C, stirred for 5 h, and a sample was taken. HPLC test showed that there was basically no purple salvia miltiorrhiza The product was not further processed.

[0039] Comparative Example 3

[0040] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate into a 50 mL single-necked flask, add a magnetic bar and 9 mL of acetonitrile, 1 mL of water, and stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, take a sample for HPLC detection, and there is basically no purple danshen acid product, so no subsequent treatment is performed.

[0041] Comparative Example 4

[0042] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate into a 50 mL single-necked flask, add a magnetic bar and 9 mL of 1,4-dioxane, and 1 mL of water, stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 90 ° C, stir for 5 h, take a sample for HPLC detection, and there is basically no purple danshenone A product, so no subsequent treatment is performed.

[0043] Comparative Example 5

[0044] Weigh 396 mg (1.0 mmol, 1.0 equiv) of sodium tanshinone IIA sulfonate into a 50 mL single-necked flask, add a magnetic bar and 18 mL of 1,4-dioxane, 2 mL of water, stir, then add 444 mg (4.0 mmol, 4.0 equiv) of selenium dioxide, heat to 110 ° C, stir for 5 h, take a sample for HPLC detection, and there is basically no purple danshenone A product (<5%), and no subsequent treatment is performed.

Claims

1. A method for preparing danshen amine, characterized in that: It includes the following steps: In a solvent, under the action of selenium dioxide, sodium tanshinone IIA sulfonate undergoes the following reaction to obtain purple danshenone A; the solvent is an ether solvent or a nitrile solvent; 2. The method for preparing red danshen hormone as claimed in claim 1, characterized in that: The reaction satisfies one or more of the following conditions: (1) The ether solvent is tetrahydrofuran, 3-methylfuran, dioxolane or 1,4-dioxane; (2) The nitrile solvent is acetonitrile, propionitrile or butyronitrile; (3) The volume mass ratio of the solvent to the sodium tanshinone IIA sulfonate is 20-80 mL / g; (4) The molar ratio of the sodium tanshinone IIA sulfonate to the selenium dioxide is 1:(1-5); The temperature of the reaction described in (5) is 85-110°C.

3. The method for preparing red danshen hormone as claimed in claim 2, characterized in that: The reaction satisfies one or more of the following conditions: (1) The ether solvent is 1,4-dioxane; (2) The nitrile solvent is acetonitrile; (3) The volume mass ratio of the solvent to the sodium tanshinone IIA sulfonate is 20-55 mL / g; (4) The molar ratio of the sodium tanshinone IIA sulfonate to the selenium dioxide is 1:(1-4); The temperature of the reaction described in (5) is 90-100°C.

4. The method for preparing red danshen hormone as claimed in claim 3, characterized in that: The reaction satisfies one or more of the following conditions: (1) The volume mass ratio of the solvent to the sodium tanshinone IIA sulfonate is 25.3 g / mL or 50.5 mL / g; (2) The molar ratio of the sodium tanshinone IIA sulfonate to the selenium dioxide is 1:2; The temperature of the reaction described in (3) is 90°C.

5. The method for preparing red danshen hormone as claimed in claim 1, characterized in that: After the reaction is completed, post-processing is also included, and the post-processing steps include concentration, extraction, drying and purification.

6. The method for preparing red danshen hormone as claimed in claim 5, characterized in that: The reaction satisfies one or more of the following conditions: (1) The organic solvent used in the extraction is ethyl acetate, acetone, dichloromethane, chloroform or 1,2-dichloroethane; (2) The drying is performed using a desiccant, wherein the desiccant is anhydrous sodium sulfate and / or anhydrous magnesium sulfate; The purification step described in (3) is column chromatography separation or preparative plate separation.

7. The method for preparing red danshen hormone as claimed in claim 6, characterized in that: The reaction satisfies one or more of the following conditions: (1) The organic solvent used in the extraction is dichloromethane; (2) The desiccant is anhydrous sodium sulfate; and (3) the mobile phase of the column chromatography separation method is dichloromethane:methanol=(10-50):1 or the developing solvent of the preparative plate separation method is dichloromethane:methanol=(30-50):

1.

8. The method for preparing red danshen hormone as claimed in claim 1, characterized in that: The solvent is acetonitrile or 1,4-dioxane, the molar ratio of the sodium tanshinone IIA sulfonate to the selenium dioxide is 1:(2-4), the volume mass ratio of the solvent to the sodium tanshinone IIA sulfonate is 20-55 g / mL, and the reaction temperature is 90°C.

9. The method for preparing red danshen hormone as claimed in claim 1, characterized in that: The materials of the reaction are sodium tanshinone IIA sulfonate, selenium dioxide and the solvent.

10. The method for preparing red danshen hormone as claimed in claim 1, characterized in that: In the reaction, sodium tanshinone IIA sulfonate is first added to the solvent, and then the selenium dioxide is added.